TRIB — Trinity Biotech Share News
0.000.00%
Last trade - 00:00- $5.11m
- $137.96m
- $43.79m
Brief: Trinity Biotech Secures Key Regulatory Approval For Offshored And Outsourced Manufacturing Of Its Flagship Rapid Hiv Test
Trinity Biotech PLC reports results for the quarter ended December 31 - Earnings Summary
Brief: Trinity Biotech Receives Non-Compliance Notice Regarding Nasdaq Global Select Requirement For Minimum Market Value Of Publicly Held Shares And Nasdaq Minimum Bid Price Requirement
U.S. STOCKS ON THE MOVE-MeiraGTx, CervoMed, Natgas companies
U.S. STOCKS ON THE MOVE-Metropolitan Bank, Fossil, MeiraGTx
U.S. STOCKS ON THE MOVE-Xpeng, D-Wave Quantum, Trinity Biotech
Trinity Biotech rises after saying it will focus on CGM technology
Brief: Trinity Biotech appoints Barclays to advise on ongoing strategic realignment process
Brief: Trinity Biotech Reports Landmark First-Day Accuracy Gains in CGM Pre-Pivotal Trial
Brief: Trinity Biotech Monitoring Potential Impact Of U.S. President’S Executive Order On Reevaluating And Realigning United States Foreign Aid
U.S. STOCKS ON THE MOVE-Sharps Technology, Smithfield Foods, Coca-Cola
Trinity Biotech rises on glucose monitoring system data
Brief: Trinity Biotech Announces Amended Credit Agreement With Perceptive To Enhance Liquidity And Drive Transformation Plan
Brief: Trinity Biotech Receives Early Approval From World Health Organization To Begin Offshore Manufacturing Of Trinscreen HIV & Uni-Gold Hiv
Trinity Biotech PLC reports results for the quarter ended September 30 - Earnings Summary
Brief: Trinity Biotech Regains Compliance With Nasdaq Listing Requirements
Brief: Trinity Biotech Enters Oncology Space With Acquisition Of Prostate Cancer Focused Epicapture
Brief: Trinity Biotech Announces Strategic Investment In Novus Diagnostics To Advance Rapid Sepsis Testing Platform
Brief: Trinity Biotech Announces Positive Pre-Pivotal Trial Results For Its Next-Generation Continuous Glucose Monitor Technology